ANEB — ANEBULO PHARMACEUTICALS INC

Ownership history in Rangeley Capital, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Rangeley Capital, LLC reported a position in ANEBULO PHARMACEUTICALS INC (ANEB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2025 Q3)
Avg. % of fund
0.04%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 50,000 +30,000 +150.0% 0.04% $50K $1.01
2025 Q3 INITIATED 20,000 — — 0.04% $50K $2.50
% of Fund (quarterly)    ANEB price (monthly, adj. close)

Other funds also holding ANEB

As of 2025 Q4 — sorted by position size

22NW, LP 3Y 7Y 35.68% MANGROVE PARTNERS IM, LLC 3Y 7Y 0.21% Nantahala Capital Management, LLC 3Y 7Y 0.1% Ikarian Capital, LLC 3Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.0% MORGAN STANLEY 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% VANGUARD GROUP INC 3Y 7Y 0.0% CITADEL ADVISORS LLC 3Y 7Y 0.0%
← Back to Rangeley Capital, LLC Holdings